Stock data
Immunome, Inc. (IMNM)
Immunome, Inc. (IMNM) reported revenue of US$6.94M and net income of -US$212.39M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$6.94M | — | -US$224.11M | -US$212.39M | — |
| 2024 | US$9.04M | — | -US$305.80M | -US$292.96M | — |
| 2023 | US$14.02M | — | -US$109.53M | -US$106.81M | — |
| 2022 | — | — | -US$36.90M | -US$36.90M | — |
| 2021 | — | — | -US$25.20M | -US$24.71M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$73.13M | — |
| 2026-03-31 | US$0.00M | -US$53.84M | — |
| 2025-12-31 | US$0.00M | -US$69.90M | — |
| 2025-09-30 | US$0.00M | -US$57.46M | — |
| 2025-06-30 | US$4.01M | -US$43.40M | — |
| 2025-03-31 | US$2.93M | -US$41.64M | — |
| 2024-12-31 | US$2.74M | -US$80.25M | — |
| 2024-09-30 | US$2.91M | -US$47.10M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.